GGrantIndex
← Leaderboards

Juan M. Pascual

Ut Southwestern Medical Center

$10,073,821
Attributed
$12,982,294
Total exposure
11
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,982,294 · 11

By mechanism

R01$8,621,397 · 4
RM1$3,657,503 · 1
R56$539,677 · 1
U54$114,339 · 1
P41$44,378 · 3
R13$5,000 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainUnited States National Institutes Of HealthMetabolismMetabolicMutationMissionPerformanceFunctional DisorderCitric Acid CycleGenesBrain MetabolismBiochemicalGlucoseClinical TrialsFatty Acid Glycerol EstersKetogenic DietLaboratoriesNeurophysiology - Biologic FunctionMouse ModelKetone BodiesSeizuresEpilepsyCarbonBase

Grant awards (27)

Mechanisms of Motor Superperformance$590,870
R01 · FY2025 · NS · contact PI
Brain glucose deficiency: mechanisms and modulation$1,875,099
RM1 · FY2024 · NS · contact PI
Mechanisms of Motor Superperformance$566,625
R01 · FY2024 · NS · contact PI
The 11th international Glut1 deficiency summit$5,000
R13 · FY2024 · NS · contact PI
Brain glucose deficiency: mechanisms and modulation$1,782,404
RM1 · FY2023 · NS · contact PI
Mechanisms of motor superperformance$539,677
R56 · FY2022 · NS · contact PI
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy$354,375
R01 · FY2021 · NS · contact PI
Dietary treatment of Glut1 deficiency (G1D) - Revision - 1$163,956
R01 · FY2021 · NS · contact PI
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)$554,982
R01 · FY2020 · NS · contact PI
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy$354,375
R01 · FY2020 · NS · contact PI
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)$809,360
R01 · FY2019 · NS · contact PI
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy$354,375
R01 · FY2019 · NS · contact PI
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)$808,735
R01 · FY2018 · NS · contact PI
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy$354,375
R01 · FY2018 · NS · contact PI
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)$807,752
R01 · FY2017 · NS · contact PI
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy$354,375
R01 · FY2017 · NS · contact PI
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)$824,012
R01 · FY2016 · NS · contact PI
Modulation of neural function in energy failure$347,813
R01 · FY2016 · NS · contact PI
Modulation of neural function in energy failure$347,813
R01 · FY2015 · NS · contact PI
Modulation of neural function in energy failure$344,335
R01 · FY2014 · NS · contact PI
Modulation of neural function in energy failure$335,639
R01 · FY2013 · NS · contact PI
Modulation of neural function in energy failure$347,630
R01 · FY2012 · NS · contact PI
NMR obervation of muscle and brain oxidative metabolism$49,339
U54 · FY2012 · NS · contact PI
NMR obervation of muscle and brain oxidative metabolism$65,000
U54 · FY2011 · NS · contact PI
NEUROLOGICAL DISEASES DUE TO INBORN ERRORS OF METABOLISM$16,082
P41 · FY2011 · RR · contact PI
NEUROLOGICAL DISEASES DUE TO INBORN ERRORS OF METABOLISM$10,458
P41 · FY2010 · RR · contact PI
NEUROLOGICAL DISEASES DUE TO INBORN ERRORS OF METABOLISM$17,838
P41 · FY2009 · RR · contact PI